BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MyoScience Inc. Receives CE Mark for Novel Cryotherapy Technology


12/8/2011 8:30:36 AM

REDWOOD CITY, CA (December 7th, 2011) – myoscience’s novel device technology has been granted CE Mark approval for the temporary treatment of wrinkles and pain.

Myoscience’s patented technology precisely delivers cold energy to targeted nerves. The nerves revert to a hibernating state resulting in a temporary interruption of nerve signaling to sensory receptors or muscle tissue. The effects are immediate with nothing left behind in the patient.

The hand-held device is intended for use in the physician’s office and represents a breakthrough advance relative to older, larger cryotherapy devices. The myoscience design allows for use in superficial tissues that were previously unrealistic targets for older cryotherapy devices.

“Approval of our device in Europe is a pivotal achievement that establishes myoscience as a commercial stage company and lays the foundation for global growth,” said Clint Carnell, Chief Executive Officer of myoscience. “In addition to introducing the device in Europe, we are pursuing approval in other international markets and will soon be enrolling subjects in a pivotal trial to support FDA clearance for the wrinkle indication.”

About myoscience. Myoscience is a privately held medical device company dedicated to developing innovative treatments in whichever fields it chooses to enter. Two generations of the myoscience device have already been cleared for use by the FDA. www.myoscience.com


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->